Announcements Trials

Browse Landscape

Phase

Status

Completed 2 Unknown 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 81 Colorectal Neoplasms 72 Rectal Neoplasms 47 Colonic Neoplasms 25 Pancreatic Neoplasms 24 Neoplasm Metastasis 17 Carcinoma, Hepatocellular 17 Esophageal Neoplasms 11 Cholangiocarcinoma 9 Neoplasms 7 Lymphoma, Large B-Cell, Diffuse 7 Liver Neoplasms 7 Biliary Tract Neoplasms 6 Colorectal Cancer Metastatic 5 Carcinoma, Non-Small-Cell Lung 5 Recurrence 4 Lymphoma, Extranodal NK-T-Cell 4 Gallbladder Neoplasms 4 Unspecified Adult Solid Tumor, Protocol Specific 3 Locally Advanced Rectal Cancer 3 Gastrointestinal Neoplasms 3 Esophageal Squamous Cell Carcinoma 3 Adenocarcinoma 3 Solid Tumors 2 Solid Tumor 2 Ovarian Neoplasms 2 Neurotoxicity Syndromes 2 Lymphoma 2 Lung Neoplasms 2 Locally Advanced Colon Cancer 2

Interventions

irinotecan sucrosofate 1 folfirinox 1 Taxes 1 Surgical Procedures, Operative 1 Radiotherapy 1 Radiosurgery 1 Oxaliplatin 1 Leucovorin 1 Gemcitabine 1 Folfox protocol 1 Fluorouracil 1 Albumin-Bound Paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Pancreatic Adenocarcinoma × Oxaliplatin × Clear all

NCT03528785 2021-08-02

nITRo

Centro Ricerche Cliniche di Verona

Phase 2 Unknown

Gastrointestinal

Pancreatic Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡